Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-08-09
2011-08-09
Kolker, Daniel E (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07994115
ABSTRACT:
Disclosed are TALL-1 and TALL-1 receptor protein homologues (agonists and antagonists) designed based on the three-dimensional structure of sTALL-1, eBCMA and eBAFF-R; agonist homologues of APRIL; methods of using wild-type APRIL to inhibit the activity of TALL-1; compositions comprising such homologues, nucleic acid molecules encoding such homologues, and therapeutic methods of using such compounds and compositions. Also disclosed are crystalline complexes of sTALL-1 and sTALL-1 in complex with either BCMA or BAFF-R; models of three-dimensional structures of such crystalline complexes and related structures, methods of drug design using any portion of such structures; methods of design and/or identification of regulatory peptides derived from the such structures; compounds identified by drug design using such structures; and the use of such compounds in therapeutic compositions and methods.
REFERENCES:
patent: 6297367 (2001-10-01), Tribouley
patent: 6403770 (2002-06-01), Yu et al.
patent: 6475987 (2002-11-01), Shu
patent: 6812327 (2004-11-01), Yu et al.
patent: 2003/0099990 (2003-05-01), Shu
patent: 2003/0148445 (2003-08-01), Shu
patent: 2007/0015695 (2007-01-01), Zhang et al.
patent: WO 00/43032 (2000-07-01), None
patent: WO 00/68378 (2000-11-01), None
patent: WO 02/16412 (2002-02-01), None
patent: WO 03/022877 (2003-03-01), None
Roschke et al., J. Immunol., vol. 169, 4314-4321, 2002.
Liu et al., Cell, vol. 108, 383-394, 2002.
Thompson et al., Science, vol. 293, 2108-2111, 2001.
Khare et al., Trends in Immunology, vol. 22, No. 2, 61-63, 2001.
Yu et al., Dept. of Inflammation, Process Science, Protein Chemistry, Pharmocology and Pathology, Amgen Inc., 252-256, 2000.
Yan et al., Nature Immunology, vol. 1(1), 37-41, 2000.
Xia et al., J. Exp. Med., vol. 192(1), 137-143, 2000.
Thompson et al., J. Exp. Med., vol. 192(1), 129-135, 2000.
Shu and Johnson, PNAS, vol. 97(16), 9156-9161, 2000.
Marsters et al., Curr. Biol., vol. 10, 785-788, 2000.
Gross et al., Nature, vol. 404, 995-999, 2000.
Chan et al., Science, vol. 288, 2351-2354, 2000.
Shu et al., J. Leukoc. Biol., vol. 65, 680-683, 1999.
Schneider et al., J. Exp. Med., vol. 189(11), 1747-1756, 1999.
Mukhopadhyay et al., J. Biol. Chem., vol. 274(23), 15978-15981, 1999.
Moore et al., Science, vol. 285, 260-263, 1999.
Holm and Sander, J. Mol. Biol., vol. 233, 123-138, 1993.
Banner et al., Cell, vol. 73, 431-445, 1993.
Eck, et al., “The Structure of Tumor Necrosis Factor-a at 2.6 Å Resolution”, The Journal of Biological Chemistry, Oct. 15, 1989, vol. 264, No. 29, pp. 17595-17605.
Karpusas, et al., “Crystal Structure of Extracellular Human BAFF, a TNF Family member that Stimulates B Lymphocytes”, Journal of Molecular Biology, Feb. 1, 2002, vol. 315, No. 5, pp. 1145-1154.
Yu, et al., “April and Tall-I and Recceptors BCMA and TACI: System for Regulationg Humoral Immunity”, Nature Immunology, Sep. 2000, Cvol. 1, No. 3, pp. 252-256.
Communication for European Patent Application No. 02802221.8, dated May 20, 2009.
Communication for European Patent Application No. 02802221.8, dated Jun. 19, 2008.
Communication for European Patent Application No. 02802221.8, Feb. 26, 2007.
Supplementary European Search Report for European Patent Application No. 02802221.8, dated Jan. 31, 2006.
Supplementary Partial European Search Report for European Patent Application No. 02802221.8, dated Nov. 14, 2005.
International Search Report for International (PCT) Patent Application No. PCT/US02/34376, mailed Dec. 15, 2004.
International Preliminary Examination Report for International (PCT) Patent Application No. PCT/US02/34376, mailed Oct. 26, 2005.
Communication for European Patent Application No. 02802221.8, dated May 4, 2010.
Liu Yingfang
Shu Hong-Bing
Xu Liangguo
Zhang Gongyi
Emch Gregory S
Kolker Daniel E
National Jewish Health
Sheridan & Ross P.C.
LandOfFree
Three-dimensional structures of TALL-1 and its cognate... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Three-dimensional structures of TALL-1 and its cognate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Three-dimensional structures of TALL-1 and its cognate... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2723548